Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress

Go back to Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
(NASDAQ: ELVN) Delayed: 46.32 +1.22 (2.71%)
Previous Close $45.10    52 Week High
Open $45.26    52 Week Low
Day High $48.52    P/E N/A 
Day Low $45.25    EPS
Volume 1,377,744